We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Tufts: PBM Exclusions Lists Pose Hurdles for Drug Developers
Tufts: PBM Exclusions Lists Pose Hurdles for Drug Developers
As pharmacy benefit managers’ exclusion lists grow longer, drug developers hoping to avoid exclusion must scramble to demonstrate the clinical superiority and cost-effectiveness of their products, according to a new report.